Melinta Therapeutics (MLNT) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free MLNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Melinta Therapeutics Short Interest DataCurrent Short Volume2,170,000 sharesPrevious Short Volume2,030,000 sharesChange Vs. Previous Month+6.90%Dollar Volume Sold Short$1.09 millionShort Interest Ratio / Days to Cover3.7Last Record DateJanuary 15, 2020Outstanding Shares13,750,000 sharesFloat Size10,370,000 sharesShort Percent of Float20.93%Today's Trading Volume0 sharesAverage Trading Volume713,628 sharesToday's Volume Vs. Average0% Short Selling Melinta Therapeutics ? Sign up to receive the latest short interest report for Melinta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMLNT Short Interest Over TimeMLNT Days to Cover Over TimeMLNT Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Melinta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20202,170,000 shares $1.09 million +6.9%20.9%3.7 $0.50 12/31/20192,170,000 shares $1.15 million +6.9%20.9%3.7 $0.53 8/15/20191,011,100 shares $2.38 million -23.9%14.2%0.4 $2.35 MLNT Short Interest - Frequently Asked Questions What is Melinta Therapeutics' current short interest? Short interest is the volume of Melinta Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 2,170,000 shares of MLNT short. 20.93% of Melinta Therapeutics' shares are currently sold short. Learn More on Melinta Therapeutics' current short interest. What is a good short interest ratio for Melinta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLNT shares currently have a short interest ratio of 4.0. Learn More on Melinta Therapeutics's short interest ratio. What is a good short interest percentage for Melinta Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.93% of Melinta Therapeutics' floating shares are currently sold short. Is Melinta Therapeutics' short interest increasing or decreasing? Melinta Therapeutics saw a increase in short interest in January. As of January 15th, there was short interest totaling 2,170,000 shares, an increase of 6.9% from the previous total of 2,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Melinta Therapeutics' float size? Melinta Therapeutics currently has issued a total of 13,750,000 shares. Some of Melinta Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Melinta Therapeutics currently has a public float of 10,370,000 shares. How does Melinta Therapeutics' short interest compare to its competitors? 20.93% of Melinta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Melinta Therapeutics: Cumberland Pharmaceuticals Inc. (0.22%), Adial Pharmaceuticals, Inc. (26.72%), Cadrenal Therapeutics, Inc. (2.04%), Protagenic Therapeutics, Inc. (0.28%), Tenax Therapeutics, Inc. (1.88%), Clever Leaves Holdings Inc. (0.61%), Trevena, Inc. (0.33%), eFFECTOR Therapeutics, Inc. (7.16%), Enveric Biosciences, Inc. (1.40%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($19.32 billion), Charter Communications, Inc. ($5.12 billion), Advanced Micro Devices, Inc. ($4.72 billion), Microchip Technology Incorporated ($3.73 billion), Match Group, Inc. ($2.38 billion), Snap Inc. ($2.17 billion), Wayfair Inc. ($2.11 billion), Uber Technologies, Inc. ($2.09 billion), Omnicom Group Inc. ($2.05 billion), and Hormel Foods Co. ($1.85 billion). View all of the most shorted stocks. What does it mean to sell short Melinta Therapeutics stock? Short selling MLNT is an investing strategy that aims to generate trading profit from Melinta Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Melinta Therapeutics? A short squeeze for Melinta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MLNT, which in turn drives the price of the stock up even further. How often is Melinta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLNT, twice per month. The most recent reporting period available is January, 15 2020. More Short Interest Resources from MarketBeat Related Companies: Cumberland Pharmaceuticals Short Squeeze Adial Pharmaceuticals Short Squeeze Cadrenal Therapeutics Short Squeeze Protagenic Therapeutics Short Squeeze Tenax Therapeutics Short Squeeze Clever Leaves Short Squeeze Trevena Short Squeeze eFFECTOR Therapeutics Short Squeeze Enveric Biosciences Short Squeeze Shuttle Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MLNT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings